MONCTON, N.B. – A class action lawsuit has been filed against a New Brunswick medical marijuana producer after unapproved pesticides were found in its products.
Wagners Law Firm alleges roughly 2,000 people purchased cannabis products containing myclobutanil and bifenazate from Moncton’s Organigram Inc. last year.
The law firm says both chemicals are considered toxic and are not authorized for use on medical cannabis, and says users are worried about the health effects.
It says Organigram recalled five lots of product in December and 69 lots in January before the company’s organic certification was suspended.
Organigram did not immediately return a request for comment Monday. But the company said in a Feb. 27 press release that its internal investigation was inconclusive, with no evidence “leading to the source of the contamination discovered.”
Wagners says the proposed representative plaintiff — writer Dawn Rae Downton — consumed the cannabis for nearly a year before learning she was exposing herself to banned pesticides.
The statement of claim alleges Organigram breached its contract with customers to provide a certified organic product free from unauthorized pesticides.
The firm says Organigram originally offered a refund to customers, but later reversed its position and offered credit for future purchases.
- This is the Buds2Go Staff Account. We work really hard to provide information and news about marijuana legalization, product information and promotional events going on across Canada. We are fanatics and experts on strains and utilizing medical cannabis for the treatment of common ailments.
- Video2019.02.07Where should Canadians go to buy weed online?
- News2018.10.19‘A 24/7 thing’: Ottawa police begin checkstop blitz to target cannabis-impaired drivers — even in the morning
- News2018.10.19Toronto police raid 5 marijuana dispensaries as retail locations still not permitted – Toronto
- News2018.10.19Former task force chair says everyone needs to obey the rules on legalized cannabis – New Brunswick